Save time and get answers to complex questions with AI chat
What are the liver enzyme requirements for starting terbinafineWhen does the apixaban patent expire?Adefovir dipivoxil discount cardIs liver function monitoring necessary with lipitorEnhertu loss of exclusivity patent expiration
See the DrugPatentWatch profile for Vyepti
Vyepti (eptinezumab-jjmr) received FDA approval on February 18, 2020. [1]
That February 18, 2020 approval was the product’s initial FDA approval date for Vyepti. [1]
The FDA approval date refers to the initial approval of Vyepti (eptinezumab-jjmr), not later updates to labeling or manufacturing changes. [1]
[1] DrugPatentWatch.com – Vyepti (eptinezumab-jjmr) FDA Approval Date
Other Questions About Vyepti :